Placebo-controlled trial of zonisamide for the treatment of alcohol dependence

Journal of Clinical Psychopharmacology

Volumn 30, Issue 3, 2010, Pages 318-322

  Arias, Albert J ^a   Feinn, Richard ^a   Oncken, Cheryl ^a   Covault, Jonathan ^a   Kranzler, Henry R ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

Alcohol dependence; Alcoholism; Pharmacotherapy; Treatment; Zonisamide

Indexed keywords

ANTIDEPRESSANT AGENT; GAMMA GLUTAMYLTRANSFERASE; PLACEBO; ZONISAMIDE;

ADULT; AGED; ALCOHOLISM; ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ENZYME ACTIVITY; ETHNICITY; FATIGUE; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; MALE; MENTAL DISEASE; MUSCULOSKELETAL DISEASE; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; RANDOMIZED CONTROLLED TRIAL; SOMNOLENCE; UROGENITAL TRACT DISEASE;

ADOLESCENT; ADULT; AGED; ALCOHOLISM; DOUBLE-BLIND METHOD; FEMALE; HUMANS; ISOXAZOLES; MALE; MIDDLE AGED; PILOT PROJECTS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77952326997     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3181db38bb     Document Type: Article

References (24)

1. Ait-Daoud N, Malcolm RJ Jr, Johnson BA. An overview of medications for the treatment of alcohol withdrawal and alcohol dependence with an emphasis on the use of older and newer anticonvulsants. Addict Behav. 2006;31(9):1628-1649.
2. Johnson BA, Ait-Daoud N, Bowden CL, et al. Oral topiramate for treatment of alcohol dependence: a randomised controlled trial. Lancet. 2003;361(9370):1677-1685.
3. Johnson BA, Rosenthal N, Capece JA, et al. Topiramate for treating alcohol dependence: a randomized controlled trial. JAMA. 2007;298(14):1641-1651.
4. White HS. Mechanism of action of newer anticonvulsants. J Clin Psychiatry. 2003;64(suppl 8):5-8.
5. Perucca E. Clinical pharmacology and therapeutic use of the new antiepileptic drugs. Fundam Clin Pharmacol. 2001;5(6):405-417.
6. McElroy SL, Kotwal R, Hudson JI, et al. Zonisamide in the treatment of binge-eating disorder: an open-label, prospective trial. J Clin Psychiatry. 2004;65(1):50-56.
7. Ueda Y, Doi T, Tokumaru J, et al. Effect of zonisamide on molecular regulation of glutamate and GABA transporter proteins during epileptogenesis in rats with hippocampal seizures. Brain Res Mol Brain Res. 2003;116(1-2):1-6.
8. Yoshida S, Okada M, Zhu G, et al. Effects of zonisamide on neurotransmitter exocytosis associated with ryanodine receptors. Epilepsy Res. 2005;67(3):153-162.
9. Yamamura S, Saito H, Suzuki N, et al. Effects of zonisamide on neurotransmitter release associated with inositol triphosphate receptors. Neurosci Lett. 2009;454(1):91-96.
10. Okada M, Kaneko S, Hirano T, et al. Effects of zonisamide on dopaminergic system. Epilepsy Res. 1995;22(3):193-205.
11. Okada M, Hirano T, Kawata Y, et al. Biphasic effects of zonisamide on serotonergic system in rat hippocampus. Epilepsy Res. 1999; 34(2-3):187-197.
12. Knapp CM, Mercado M, Markley TL, et al. Zonisamide decreases ethanol intake in rats and mice. Pharmacol Biochem Behav. 2007;87(1):65-72.
13. Sarid-Segal O, Knapp CM, Burch W, et al. The anticonvulsant zonisamide reduces ethanol self-administration by risky drinkers. Am J Drug Alcohol Abuse. 2009;35(5):316-319.
14. Gadde KM, Franciscy DM, Wagner HR, et al. Zonisamide for weight loss in obese adults: a randomized controlled trial. JAMA. 2003;289(14):1820-1825.
15. McElroy SL, Kotwal R, Guerdjikova AI, et al. Zonisamide in the treatment of binge eating disorder with obesity: a randomized controlled trial. J Clin Psychiatry. 2006;67(12):1897-1906.
16. Anand A, Bukhari L, Jennings SA, et al. A preliminary open-label study of zonisamide treatment for bipolar depression in 10 patients. J Clin Psychiatry. 2005;66(2):195-198.
17. Baldassano CF, Ghaemi SN, Chang A, et al. Acute treatment of bipolar depression with adjunctive zonisamide: a retrospective chart review. Bipolar Disord. 2004;6(5):432-434.
18. Ghaemi SN, Zablotsky B, Filkowski MM, et al. An open prospective study of zonisamide in acute bipolar depression. J Clin Psychopharmacol. 2006;26(4):385-388.
19. Kanba S, Yagi B, Kamijima K, et al. The first open study of zonisamide, a novel anticonvulsant, shows efficacy in mania. Prog Neuropsychopharmacol Biol Psychiatry. 1994;18(4):707-715.
20. McElroy SL, Suppes T, Keck PE Jr, et al. Open-label adjunctive zonisamide in the treatment of bipolar disorders: a prospective trial. J Clin Psychiatry. 2005;66(5):617-624.
21. Ghaemi SN, Shirzadi AA, Klugman J, et al. Is adjunctive open-label zonisamide effective for bipolar disorder? J Affect Disord. 2008; 105(1-3):311-314.
22. Sobell L, Sobell M. Timeline follow-back: a technique for assessing self-reported alcohol consumption. In: Litten R, Allen J, eds. Measuring Alcohol Consumption. Clifton, New Jersey: Humana Press; 1992.
23. Bohn MJ, Krahn DD, Staehler BA. Development and initial validation of a measure of drinking urges in abstinent alcoholics. Alcohol Clin Exp Res. 1995;19(3):600-606.
24. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-571.